PHK
AXSM icon

Point72 Hong Kong’s Axsome Therapeutics AXSM Stock Holding History

Point72 Hong Kong’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$389K Buy
+3,203
New +$361K 0.02% 274
2021
Q2 		– Sell
-214
Closed -$12K – 1916
2021
Q1 		$12K Buy
214
+187
+693% +$13.2K ﹤0.01% 1562
2020
Q4 		$2K Sell
27
-475
-95% -$35.5K ﹤0.01% 1638
2020
Q3 		$36K Sell
502
-1,236
-71% -$96.3K ﹤0.01% 747
2020
Q2 		$143K Buy
+1,738
New +$134K 0.02% 563
2020
Q1 		– Sell
-65
Closed -$7K – 954
2019
Q4 		$7K Sell
65
-966
-94% -$39K ﹤0.01% 1014
2019
Q3 		$21K Buy
+1,031
New +$26.5K 0.01% 701

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Hong Kong's AXSM Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Axsome Therapeutics (AXSM) in Q3 2025: 3,203 shares worth $389K. The stake represents 0.02% of the portfolio and ranks #274 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in AXSM as recently as Q1 2021.

Point72 Hong Kong first reported a position in AXSM in Q3 2019 and has held it in 7 quarters since. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Point72 Hong Kong held 3,203 shares of Axsome Therapeutics worth $389K as of Q3 2025.
  • Axsome Therapeutics was a new Point72 Hong Kong position in Q3 2025.
  • Axsome Therapeutics made up 0.02% of Point72 Hong Kong's portfolio in Q3 2025, its #274 holding.
  • Point72 Hong Kong first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 7 quarters since.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.